aggrego News

 
Acute Basal Cell Carcinoma
More
Diagnosing Basal Cell Carcinoma: Optical Coherence Tomography vs Punch Biopsy
The ASCO Post
Deep Learning on Reflectance Confocal Microscopy Improves Raman Spectral Diagnosis of Basal Cell Carcinoma
Journal of Biomedical Optics
Topical HDAC Inhibitor Remetinostat for Basal Cell Carcinoma
The ASCO Post
Hedgehog Inhibitor Alternative Dosing Advantageous for BCC
Medscape
Genetic and Functional Interaction Network Analysis Reveals Global Enrichment of Regulatory T Cell Genes Influencing Basal Cell Carcinoma Susceptibility
Genome Medicine
Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities
Molecules
Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial.
Journal of Dermatological Treatment
Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer
Facial Plastic Surgery
Evaluation of ultrahigh‐resolution optical coherence tomography for basal cell carcinoma, seborrheic keratosis, and nevus
Skin Research and Technology
Acute Myeloid Leukemia
More
Busulfan Plus Fludarabine Compared With Busulfan Plus Cyclophosphamide for AML Undergoing HLA-Haploidentical Hematopoietic Cell Transplantation
Journal of Clinical Oncology
Intensive Chemotherapy With or Without Gemtuzumab Ozogamicin in Patients With NPM1-mutated Acute Myeloid Leukemia
The Lancet Hematology
Single-cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal Hyperexpansion
Cancer Immunology Research
MD Anderson Awarded Over $5.7 Million from Break Through Cancer to Support AML Research
MD Anderson
Combined Inhibition of BCL-2 and MCL-1 Overcomes BAX Deficiency-mediated Resistance of TP53-mutant Acute Myeloid Leukemia to Individual BH3 Mimetics
Blood Cancer Journal
Addition of Quizartinib to Chemotherapy in Newly Diagnosed FLT3-ITD-Positive Acute Myeloid Leukemia
The ASCO Post
Sorafenib Maintenance Post-Transplantation Among Patients With FLT3-ITD Mutated AML
Oncology Learning Network
Impact of Type of Induction Therapy on Outcomes in Older Adults With AML After Allogeneic Stem Cell Transplantation
Blood Advances
The Complement Receptor C3AR Constitutes a Novel Therapeutic Target in NPM1-mutated AML
Blood Advances
Breast Cancer
More
IDEAYA Biosciences Receives Fast Track Designation for IDE161 in a Second Indication for the Treatment of Pretreated, Advanced or Metastatic HR+, HER2-, BRCA1/2 Mutant Breast Cancer
PR Newswire
Air Pollution Linked to Increased Risk of Breast Cancer
Oncology Nurse Advisor
Correlation Found Between Treatment Interruptions During Adjuvant Radiotherapy and Overall Survival Among Patients With Triple-Negative Breast Cancer
Oncology Learning Network
ER-Positive Breast Cancer: Addition of Adjuvant Ovarian Function Suppression to Tamoxifen in Premenopausal Patients
The ASCO Post
Breast Screening Participation and Degree of Spread of Invasive Breast Cancer at Diagnosis in Mental Health Service Users
Cancer
Exploring Autonomic Modulation: Day-to-Day Recovery After Exercise Sessions Among Survivors of Breast Cancer
Frontiers in Oncology
Open-label Phase I Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor–positive Breast Cancer
Clinical Cancer Research
Taste, Smell Changes During Chemo Affect QOL in Breast Cancer Patients
Cancer Therapy Advisor
Radiomic Signatures Based on Pretreatment 18F-FDG PET/CT, Combined With Clinicopathological Characteristics, as Early Prognostic Biomarkers Among Patients With Invasive Breast Cancer
Frontiers in Oncology
Chronic ITP
More
A Single-Arm, Long-Term Efficacy and Safety Study of Subcutaneous Romiplostim in Children With Immune Thrombocytopenia
Blood Advances
Venous Thromboembolism in Cancer Patients: ESMO Clinical Practice Guideline
Annals of Oncology
Study Finds Racial Disparities in Cancer-Associated Thrombosis
Cancer Therapy Advisor
Non-O Blood Type May Increase VTE Risk in Patients With Cancer
Medscape
Early Treatment of Rituximab Combined With Eltrombopag for Secondary Thrombocytopenic Purpura in Rheumatoid Arthritis
Medicine
cITP Associated With Familial Autoimmune Dysregulation
Oncology Learning Network
SDF-1α Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients With Immune Thrombocytopenia
Stem Cells International
Quantitative LC–MS/MS Uncovers the Regulatory Role of Autophagy in Immune Thrombocytopenia
Cancer Cell International
Unexpected Thrombocytosis Could Flag Occult Cancer
Medscape
Colorectal Cancer
More
Size and Depth of Residual Tumor After Neoadjuvant Chemoradiotherapy in Rectal Cancer
Frontiers in Oncology
A Machine Learning-Based Model for Predicting Distant Metastasis in Patients With Rectal Cancer
Frontiers in Oncology
Effect of HER2 Overexpression or Amplification on Resistance to Anti-EGFR Treatment Among Patients with RAS Wild-Type Metastatic Colorectal Cancer
Oncology Learning Network
Plasma 25-hydroxyvitamin D Levels and Survival in Stage 3 Colon Cancer: Findings From CALGB/SWOG 80702
Clinical Cancer Research
The Use of Quantitative T1-mapping to Identify Cells and Collagen Fibers in Rectal Cancer
Frontiers in Oncology
Treatment of BRAF-V600E Mutant Metastatic Colorectal Cancer: New Insights and Biomarkers
Expert Review of Anticancer Therapy
Tumor Avatars Show Promise in Personalized Cancer Treatment
Oncology Times
Jacobio Pharma Presents Clinical Results of Glecirasib in Colorectal Cancer
PR Newswire
Risk-adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study
Journal of Clinical Oncology
FDA Approvals
More
US FDA Approves Aston Sci.'s Phase 2 IND for Ovarian Cancer Vaccine, AST-201
PR Newswire
FDA Approval Summary: Tremelimumab in Combination With Durvalumab for the Treatment of Patients With Unresectable Hepatocellular Carcinoma
Clinical Cancer Research
BioProtect Receives FDA's Clearance for its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy
PR Newswire
US FDA Approves Niraparib and Abiraterone Acetate, the First-And-Only Dual Action Tablet for the Treatment of Patients With BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
PR Newswire
FDA Approves Pralsetinib for Locally Advanced, Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer
Oncology Learning Network
FDA Approval of Trifluridine and Tipiracil With Bevacizumab for Patients With Previously Treated Metastatic Colorectal Cancer
Oncology Learning Network
FDA Approves Dostarlimab Plus Carboplatin and Paclitaxel for Advanced or Recurrent dMMR/MSI-H Endometrial Cancer
Oncology Learning Network
ExThera Medical Announces FDA Approval of IDE Application for Use of the OncoBind Extracorporeal Procedure to Remove Circulating Tumor Cells in Patients With Pancreatic Cancer
businesswire
FDA Grants Accelerated Approval to Glofitamab for Patients With R/R Diffuse Large B-Cell Lymphoma
Oncology Learning Network
Follicular Lymphoma
More
Zanubrutinib Plus Obinutuzumab vs Obinutuzumab Monotherapy for Patients With R/R Follicular Lymphoma
Oncology Learning Network
First-Line Subcutaneous Rituximab May Increase PFS in Low Tumor Burden FL
ASH Clinical News
Prognostic Value of PET Status for Patients With R/R Follicular Lymphoma Undergoing AutoSCT
Oncology Learning Network
AbbVie and Genmab Announce Positive Topline Results From Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients With Relapsed/Refractory Follicular Lymphoma
AbbVie
Survival Rates of Histological Transformation in Patients With Follicular Lymphoma
Oncology Learning Network
Low T3 Syndrome as a Predictor of Poor Outcomes in Patients With Follicular Lymphoma
Annals of Hematology
Odronextamab Appears Safe, Effective in Relapsed/Refractory Follicular Lymphoma
Cancer Therapy Advisor
Addition of Atezolizumab to Obinutuzumab-Bendamustine Does Not Improve PFS in Previously Untreated Follicular Lymphoma
Hematology Advisor
Novel, Minimally Invasive Test Detects Higher Frequency of EZH2 Mutations in Follicular Lymphoma
Oncology Learning Network